Diclofenac
Back to searchMolecule Structure
Scientific Name
Diclofenac
Description of the Drug
Diclofenac is an NSAID used to treat the signs and symptoms of osteoarthritis and rheumatoid arthritis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00586
http://www.drugbank.ca/drugs/DB00586
Brand Name(s)
Cambia, Voltaren, Voltaren Ophthalmic, Voltaren Xr, Zorvolex, Zorvolex capsules
Company Owner(s)
Cipla Ltd, Alkem Laboratories Ltd, Horizon Therapeutics Ireland Dac, Sun Pharmaceutical Industries Inc, Watson Laboratories Inc, Fougera Pharmaceuticals Inc, Actavis Mid Atlantic Llc, Taro Pharmaceuticals Usa Inc, Falcon Pharmaceuticals Ltd, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Cyclooxygenase | PROTEIN FAMILY | INHIBITOR | CHEMBL2094253 |
Clinical Trial(s)
Unichem Links
Atlas | diclofenac | ||||||||||||||
SureChEMBL | SCHEMBL2799 | ||||||||||||||
PharmGKB | PA449293 | ||||||||||||||
Human Metabolome Database | HMDB0014724 | ||||||||||||||
DrugBank | DB00586 | ||||||||||||||
PubChem: Thomson Pharma | 14873560 | ||||||||||||||
PubChem | 3033 | ||||||||||||||
Mcule | MCULE-1824024270 | ||||||||||||||
NMRShiftDB | 20242371 | ||||||||||||||
LINCS | LSM-2160 | ||||||||||||||
Nikkaji | J8.557J | ||||||||||||||
PDBe | DIF | ||||||||||||||
BindingDB | 13066 | ||||||||||||||
EPA CompTox Dashboard | DTXSID6022923 | ||||||||||||||
DrugCentral | 865 | ||||||||||||||
Brenda | 154422 | 69451 | 153432 | ||||||||||||
ChemicalBook | CB5225367 | ||||||||||||||
Guide to Pharmacology | 2714 | ||||||||||||||
rxnorm | DICLOFENAC POTASSIUM | ZIPSOR | DICLOFENAC | ARTHROTEC | FLECTOR | DYLOJECT | PENNSAID | CATAFLAM | DICLOFENAC EPOLAMINE | DICLOFENAC SODIUM | VOLTAREN | ZORVOLEX | CAMBIA | SOLARAZE | LICART |
KEGG Ligand | C01690 | ||||||||||||||
ChEBI | 47381 | ||||||||||||||
ZINC | ZINC000000001281 |